Total planned funding: $5,946,829,451
Allocations
Countries/Regions
Nigeria | $1,157,850,857 |
Tanzania | $939,831,175 |
Zambia | $849,683,459 |
Mozambique | $564,643,933 |
Uganda | $468,566,666 |
Côte d'Ivoire | $261,715,793 |
Kenya | $248,863,965 |
Zimbabwe | $239,884,338 |
Ethiopia | $227,553,988 |
Rwanda | $207,812,980 |
Haiti | $145,818,320 |
South Africa | $138,539,097 |
Democratic Republic of the Congo | $103,463,392 |
Vietnam | $94,885,708 |
Namibia | $75,751,021 |
Eswatini | $57,284,885 |
Cameroon | $31,355,723 |
Malawi | $26,197,735 |
Ukraine | $16,579,088 |
Lesotho | $15,119,906 |
Botswana | $14,134,059 |
Burundi | $11,993,630 |
Guyana | $11,838,291 |
West Africa Region | $9,946,029 |
Western Hemisphere Region | $9,127,948 |
South Sudan | $9,004,626 |
Ghana | $1,972,516 |
Asia Regional Program | $1,385,414 |
Indonesia | $1,380,316 |
Central America Region | $1,367,580 |
Cambodia | $708,181 |
Russia | $530,000 |
Angola | $502,945 |
China | $433,921 |
Dominican Republic | $375,000 |
enumerations.Philippines | $358,416 |
Caribbean Region | $333,000 |
Central Asia Region | $35,550 |
India | $0 |
Organizational Types
Private Contractor | $5,946,829,451 |
Program Areas
Treatment | $5,946,829,451 |
Budget Codes
HTXD: Treatment: ARV Drugs | $3,996,806,437 |
HTXS: Treatment: Adult Treatment | $1,747,015,579 |
PDTX: Treatment: Pediatric Treatment | $203,007,435 |
Top Partner Programs
Chemonics International:
$2,693,260,506
View countries
Partnership for Supply Chain Management:
$2,408,749,100
View countries
Deloitte Consulting Limited:
$129,446,470
View countries
University Research Corporation, LLC:
$117,966,156
View countries